Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Fruchart

Showing results (91-100 of 538) with videos related to

Pageof 54
Sort By:
Lille Medical : Journal De La Faculte De Medecine Et De Pharmacie De L'Universite De Lille|November 1, 1970
[Study by preparative ultracentrifugation of the lipid composition of the main classes of plasma lipoproteins in normal subjects and in atherosclerosis without manifest hyperlipemia state]G Sezille, J Jaillard, P Scherpereel, et al.
Lille Medical : Journal De La Faculte De Medecine Et De Pharmacie De L'Universite De Lille|April 1, 1971
[Apropos of a case of Refsum's disease: biochemical study]G Sezille, J Jaillard, P Scherpereel, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 1, 1972
[Semi-automatic determination of post-heparin plasma lipolytic activity. Clinical studies]J Jaillard, G Sezille, J C Fruchart, et al.
Biochimie|February 1, 1997
The effects of fibrates and thiazolidinediones on plasma triglyceride metabolism are mediated by distinct peroxisome proliferator activated receptors (PPARs)B Staels, K Schoonjans, J C Fruchart, et al.
Journees Annuelles De Diabetologie De L'Hotel-Dieu|September 22, 2001
[PPARs activators and regulation of lipid metabolism, vascular inflammation and atherosclerosis]V Bocher, G Chinetti, J C Fruchart, et al.
Lancet (London, England)|November 20, 1993
Apolipoprotein E-epsilon 4 allele and Alzheimer's diseaseP Amouyel, T Brousseau, J C Fruchart, et al.
Current Medical Research and Opinion|May 21, 2010
Implications of the ACCORD lipid study: perspective from the Residual Risk Reduction Initiative (R(3)i)J C Fruchart, F M Sacks, M P Hermans, et al.
Advances in Experimental Medicine and Biology|January 1, 1988
Molecular analysis of atherogenic lipoprotein particles in adequately controlled type I diabetes mellitusC Fievet, L Méjean, P Drouin, et al.
Lille Medical : Journal De La Faculte De Medecine Et De Pharmacie De L'Universite De Lille|October 1, 1974
[Use of polyunsaturated phospholipids in the treatment of fat embolism]F Wattel, P Scherpereel, G Sezille, et al.
Annales De Biologie Clinique|January 1, 1974
[Semi-automatic colorimetric determination of fatty acids. Applications: determination of plasma free fatty acids, serum lipase and post-heparin plasma triglyceride-lipases]J C Fruchart, P Dewailly, J Jaillard, et al.
Pageof 54

Showing results (91-100 of 538) with videos related to

Sort By:
Pageof 54
Lille Medical : Journal De La Faculte De Medecine Et De Pharmacie De L'Universite De Lille|November 1, 1970
[Study by preparative ultracentrifugation of the lipid composition of the main classes of plasma lipoproteins in normal subjects and in atherosclerosis without manifest hyperlipemia state]G Sezille, J Jaillard, P Scherpereel, et al.
Lille Medical : Journal De La Faculte De Medecine Et De Pharmacie De L'Universite De Lille|April 1, 1971
[Apropos of a case of Refsum's disease: biochemical study]G Sezille, J Jaillard, P Scherpereel, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 1, 1972
[Semi-automatic determination of post-heparin plasma lipolytic activity. Clinical studies]J Jaillard, G Sezille, J C Fruchart, et al.
Biochimie|February 1, 1997
The effects of fibrates and thiazolidinediones on plasma triglyceride metabolism are mediated by distinct peroxisome proliferator activated receptors (PPARs)B Staels, K Schoonjans, J C Fruchart, et al.
Journees Annuelles De Diabetologie De L'Hotel-Dieu|September 22, 2001
[PPARs activators and regulation of lipid metabolism, vascular inflammation and atherosclerosis]V Bocher, G Chinetti, J C Fruchart, et al.
Lancet (London, England)|November 20, 1993
Apolipoprotein E-epsilon 4 allele and Alzheimer's diseaseP Amouyel, T Brousseau, J C Fruchart, et al.
Current Medical Research and Opinion|May 21, 2010
Implications of the ACCORD lipid study: perspective from the Residual Risk Reduction Initiative (R(3)i)J C Fruchart, F M Sacks, M P Hermans, et al.
Advances in Experimental Medicine and Biology|January 1, 1988
Molecular analysis of atherogenic lipoprotein particles in adequately controlled type I diabetes mellitusC Fievet, L Méjean, P Drouin, et al.
Lille Medical : Journal De La Faculte De Medecine Et De Pharmacie De L'Universite De Lille|October 1, 1974
[Use of polyunsaturated phospholipids in the treatment of fat embolism]F Wattel, P Scherpereel, G Sezille, et al.
Annales De Biologie Clinique|January 1, 1974
[Semi-automatic colorimetric determination of fatty acids. Applications: determination of plasma free fatty acids, serum lipase and post-heparin plasma triglyceride-lipases]J C Fruchart, P Dewailly, J Jaillard, et al.
Pageof 54